Dr. Trucco's Quest: Find a Vaccine Against Type 1 Diabetes Based on a Patient's Own Blood

For many long-time type 1’s, the attacks on their beta cells over the years have left them with no realistic hope of recovering the ability to produce insulin. But if a vaccine could be developed that specifically targets the misbehaving dendritic cells, it could help newer type 1’s without having to shut down the entire immune system.

Jul 9, 2009

Of all the quests that researchers have undertaken in search of a cure or decisive treatment for type 1 diabetes, the search for a vaccine has to be the boldest. But how would you develop such a vaccine, and how would it work?

Massimo Trucco, MD, an immunologist affiliated with the University of Pittsburgh School of Medicine and a director of the Juvenile Diabetes Foundation, thinks he may be on to something: a way to make the body thwart attacks by immune system killer T cells on the pancreatic beta cells that produce insulin.

What goes wrong in people with type 1 diabetes is that certain white blood cells, called dendritic cells, wrongly tell the T cells that beta cells are invaders. The T cells, consequently, kill the beta cells. (Think of dendritic cells as conniving little playground tattletales who loves to get other kids in trouble with the teachers by spreading misinformation.)

Dr. Trucco's approach is to alter molecules on the dendritic surface that the cells use to communicate. By garbling up the information that the dendritic cells deliver to the immune system, he can stop the continual T cell attacks that eventually destroy all pancreatic beta cells.

Dr. Trucco's experiments with mice, injecting them with "reprogrammed" dendritic cells from their own bodies, have worked to completely stop T cell attacks. He is currently working with 15 adults with type 1 diabetes to test a vaccine, derived from their blood, in which their dendritic cells have been altered. He injects the vaccine into the skin near the pancreas, and the cells work their way to the organ to begin offering their new message.

If the trial with adults goes well, Dr. Trucco will then begin testing the effects of reprogrammed dendritic cells on children. Also in the works is research on ways to alter dendritic cells without having to remove them from patients and then re-inject them, perhaps by using drugs.

Dr. Trucco's approach gets around a long-standing problem in the treatment of diabetes. Because it is an autoimmune disease, it could theoretically be thwarted by suppressing a patient's immune system. In real life, however, such an approach would leave type 1 patients open to infection and opportunistic diseases.

For many long-time type 1 patients, the attacks on their beta cells over the years have left them with no realistic hope of recovering the ability to produce insulin. But if a vaccine could be developed that specifically targets the misbehaving dendritic cells, it could help newer type 1's without having to shut down the entire immune system.

This Associated Press story gives more details about Dr. Trucco's research.        

Click Here To View Or Post Comments

Categories: Beta Cells, Community, Diabetes, Diabetes, Insulin, Laboratory Tests, Medications, Professional Issues, Research, Type 1 Issues, Type 2 Issues

Diabetes Health Professional
Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (2)

You May Also Be Interested In...


Posted by Green Lantern on 16 July 2009

Type 1 diabetes seems to require a genetic susceptibility plus a trigger. Cocksackie virus has been identified in research as a trigger. Why not prevent diabetes up front by developing a vaccine for cocksackie virus?

Posted by Anonymous on 17 July 2009

to produce and implant autologous panceartic stem cells and to produce anti-islet cell antibodies may be newer therapy approaches.

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.